Connect with us

Cannabis News

Cresco Labs to Acquire Tryke, One of the Most Profitable Private Cannabis Companies

Published

on

Cresco Labs has been working to establish their own leading position in the cannabis markets in Nevada and Arizona, but that can’t be done without some changes. According to reports from New Cannabis Ventures, the company will be acquiring the Reef Dispensary Portfolio, as well as other Tryke Companies.

Tryke brought in $70.4 million in revenue during fiscal 2018, as well as $24.6 million in EBITDA, making it one of the most profitable private companies in the cannabis industry, as well as one of the highest grossing companies.

Presently, Nevada is one of the fastest growing markets for cannabis in the United States, while Arizona is still one of the fastest-growing medical-only markets. Reef Dispensary is one of six best-positioned retail locations in both states, bringing in over $65 million in revenue in the last four years. Other operating locations presently include Phoenix, Las Vegas, and Sparks.

The entire transaction for Cresco Labs can be viewed at:

https://s22.q4cdn.com/545881950/files/doc_presentations/2019/09/cresco-labs-tryke-companies.pdf.

Michael is a freelance writer with several years of experience in writing of all kinds. From the uber-technical to the more relaxed, he is well-versed in a variety of styles. Lately, his work has been primarily focused on the CBD industry—a market with which he has a particular background and interest. Michael has an extensive interest and experience in legal research for the CBD market, and he has a knack for well-researched pieces and guides for the growing CBD and medicinal cannabis community.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.